SciELO - Scientific Electronic Library Online

vol.32 issue2A Successful Experience: Safety and Efficiency of Balanced Sedation with Propofol and Remifentanil in Diagnostic EndoscopyA Review of the Literature on the Use of Probiotics to Treat Irritable Bowel Syndrome and Inflammatory Bowel Disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista Colombiana de Gastroenterologia

Print version ISSN 0120-9957


GALLO E, Simón; CARABALLO C, Cesar; OROZCO M, Mateo  and  MUNOZ, Octavio Germán. Current treatment and new therapies against chronic hepatitis B virus infection. Rev Col Gastroenterol [online]. 2017, vol.32, n.2, pp.131-140. ISSN 0120-9957.

Chronic hepatitis B virus infections are a serious public health problem worldwide. Its consequences can be deadly, and current treatment offers only control of the disease rather than a cure. The main limiting factors for a cure are the difficulty of destroying the cDNA of the virus in the cell nucleus and the presence of viral genetic material integrated into the DNA of the host cell. Multiple fronts of research focus on finding a definitive cure by enhancing the immune response of the host or by acting directly against the virus and its replication cycle. This article presents the main advances that have been made in this field.

Keywords : Hepatitis B virus; Immunotherapy; Antiviral Agents; Chronic Hepatitis; Liver Cirrhosis.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )